ArticleNature2021
Underdetection of cases of COVID-19 in France threatens epidemic control.
Abstract read
In one paragraph
Article in Nature, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 132 papers.
0numbers the graph read from it
0cells of the map it votes in
132citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
132 citing papers in PubMed.
- Intensified screening for SARS-CoV-2 in 18 emergency departments in the Paris metropolitan area, France (DEPIST-COVID): A cluster-randomized, two-period, crossover trial.PLoS medicine · 2023Trial
- Epidemiology of SARS-CoV-2 Infection in Italy Using Real-World Data: Methodology and Cohort Description of the Second Phase of Web-Based EPICOVID19 Study.International journal of environmental research and public health · 2022Trial
- Results of the epidemiological measurement of endemics, epidemics, and pandemics.Infectious Disease Modelling · 2026Article
- Mobility data resolution needed to inform predictive models of spatial epidemic spread from mobile phone data.PLoS computational biology · 2026Article
- Beyond influenza-like-illness: data-driven syndromic surveillance for fine-scale monitoring of seasonal respiratory viruses.medRxiv : the preprint server for health sciences · 2026Article
- Mobility-driven synthetic contact matrices as a scalable solution for real-time pandemic response modeling.Nature communications · 2026Article
- Individual and neighborhood based socioeconomic factors relevant for contact behaviour and epidemic control.Communications medicine · 2025Article
- Optimizing surveillance post-pandemic: an evaluation of COVID-19 and other respiratory virus surveillance systems in the Philippines, April 2023.BMC public health · 2025Article
- Optimal algorithms for controlling infectious diseases in real time using noisy infection data.PLoS computational biology · 2025Article
- Changes in Physical Activity, Heart Rate, and Sleep Measured by Activity Trackers During the COVID-19 Pandemic Across 34 Countries: Retrospective Analysis.Journal of medical Internet research · 2025Article
- Planning and adjusting the COVID-19 booster vaccination campaign to reduce disease burden.Infectious Disease Modelling · 2025Article
- Characterizing US Spatial Connectivity and Implications for Geographical Disease Dynamics and Metapopulation Modeling: Longitudinal Observational Study.JMIR public health and surveillance · 2025Observational
- Interpretation of indoor air surveillance for respiratory infections: a prospective longitudinal observational study in a childcare setting.EBioMedicine · 2025Observational
- Surveillance of Excess Mortality Based on Community Perceptions of Funeral Frequency in Northern Malawi during the COVID-19 Pandemic.The American journal of tropical medicine and hygiene · 2025Article
- A comparative cross-sectional study of the impact of COVID-19 pandemic on obstetrics and gynecology admissions in Croatia.Frontiers in medicine · 2025Article
- Asymmetric limits on timely interventions from noisy epidemic data.Communications physics · 2025Article
- Effectiveness of probabilistic contact tracing in epidemic containment: The role of superspreaders and transmission path reconstruction.PNAS nexus · 2024Article
- Underreporting of Cases in the COVID-19 Outbreak of Borriana (Spain) during Mass Gathering Events in March 2020: A Cross-Sectional Study.Epidemiologia (Basel, Switzerland) · 2024Article
- Immune Characteristic Genes and Neutrophil Immune Transformation Studies in Severe COVID-19.Microorganisms · 2024Article
- Primary care indicators for disease burden, monitoring and surveillance of COVID-19 in 31 European countries: Eurodata Study.European journal of public health · 2024Article
72 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
17 authors.
Giulia Pullano *INSERM, Sorbonne Université, Institut Pierre Louis d'Epidémiologie et de Santé Publique, IPLESP, Paris, France.
Laura Di Domenico *INSERM, Sorbonne Université, Institut Pierre Louis d'Epidémiologie et de Santé Publique, IPLESP, Paris, France.
Chiara E SabbatiniINSERM, Sorbonne Université, Institut Pierre Louis d'Epidémiologie et de Santé Publique, IPLESP, Paris, France.
Eugenio ValdanoINSERM, Sorbonne Université, Institut Pierre Louis d'Epidémiologie et de Santé Publique, IPLESP, Paris, France.
Clément TurbelinINSERM, Sorbonne Université, Institut Pierre Louis d'Epidémiologie et de Santé Publique, IPLESP, Paris, France.
Marion DebinINSERM, Sorbonne Université, Institut Pierre Louis d'Epidémiologie et de Santé Publique, IPLESP, Paris, France.
Caroline GuerrisiINSERM, Sorbonne Université, Institut Pierre Louis d'Epidémiologie et de Santé Publique, IPLESP, Paris, France.
Charly Kengne-KuetcheINSERM, Sorbonne Université, Institut Pierre Louis d'Epidémiologie et de Santé Publique, IPLESP, Paris, France.
Cécile SoutyINSERM, Sorbonne Université, Institut Pierre Louis d'Epidémiologie et de Santé Publique, IPLESP, Paris, France.
Thomas HanslikINSERM, Sorbonne Université, Institut Pierre Louis d'Epidémiologie et de Santé Publique, IPLESP, Paris, France.
Thierry BlanchonINSERM, Sorbonne Université, Institut Pierre Louis d'Epidémiologie et de Santé Publique, IPLESP, Paris, France.
Pierre-Yves BoëlleINSERM, Sorbonne Université, Institut Pierre Louis d'Epidémiologie et de Santé Publique, IPLESP, Paris, France.
Julie FigoniSanté publique France, Direction des maladies infectieuses, Saint-Maurice, France.
Sophie VauxSanté publique France, Direction des maladies infectieuses, Saint-Maurice, France.ORCID http://orcid.org/0000-0001-6648-6320
Christine CampèseSanté publique France, Direction des maladies infectieuses, Saint-Maurice, France.
Sibylle Bernard-StoecklinSanté publique France, Direction des maladies infectieuses, Saint-Maurice, France.
Vittoria ColizzaINSERM, Sorbonne Université, Institut Pierre Louis d'Epidémiologie et de Santé Publique, IPLESP, Paris, France. vittoria.colizza@inserm.fr.ORCID http://orcid.org/0000-0002-2113-2374
Funding
No grant is acknowledged in the PubMed record.
Abstract
As countries in Europe gradually relaxed lockdown restrictions after the first wave, test-trace-isolate strategies became critical to maintain the incidence of coronavirus disease 2019 (COVID-19) at low levels
Indexed as
Models, BiologicalAge DistributionCarrier StateCOVID-19COVID-19 TestingFemaleFranceHealth BehaviorHospitalizationHumansIncidenceMalePandemicsPatient Acceptance of Health CarePhysical DistancingSARS-CoV-2
Identifiers
PMID
33348340What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.